Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line

OBJECTIVES: The objectives of this study were to 1) describe and compare treatment persistence with first- and second-line subcutaneous tumor necrosis factor-alpha inhibitors (SC-TNFis) in patients with ankylosing spondylitis (AS), psoriatic arthritis (PsA), or rheumatoid arthritis (RA) (collectivel...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Patient Prefer Adherence
Hlavní autoři: Svedbom, Axel, Dalén, Johan, Black, Christopher M, Kachroo, Sumesh
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2017
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5248937/
https://ncbi.nlm.nih.gov/pubmed/28144130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S119808
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky